poisar

Stocks · News reference

BMO Capital Maintains Outperform on Morningstar, Raises Price Target to $237

Benzinga Newsdesk

BMO Capital analyst Jeffrey Silber maintains Morningstar (NASDAQ:MORN) with a Outperform and raises the price target from $230 to $237.

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

MORN
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Sarah Sidlow

    Robinhood Markets Reports Earnings on Oct. 27. Is It a Better Buy Than Morningstar?

    The article compares Robinhood Markets and Morningstar as investment options for 2026. Robinhood demonstrates explosive growth with 51.6% revenue increase and 42.1% net margins, but trades at a premium valuation (P/E 48.94x) and faces significant regulatory risks. Morningstar offers stability with slower 7.5% growth, lower valuation (P/E 19.38x), and dividend income, but risks falling behind in AI adoption. The choice depends on investor risk tolerance and time horizon.

    HOODMORNAMZN
  3. SEC EDGAR

    8-K filing — Morningstar, Inc. (MORN)

    Filed: 2026-09-25 AccNo: 0001289419-26-000048 Size: 589 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

    MORN